IASLC Asia Pacific Lung Cancer Conference (APLCC) 2016 – Independent satellite symposium
Chaired by Tony Mok with Ross Soo and Giorgio Scagliotti
Held on Friday 13th May 2016, Chiang Mai, Thailand
The expert Faculty guided us through this complexity by placing the latest developments in advanced NSCLC into the context of treatment. They provided their insights into how we can use our biological knowledge not only to improve treatment pathways, but also to maximize treatment outcomes by understanding different approaches. The scientific summary includes questions that were put to the audience by the Chair, Professor Tony Mok.
Here we provide a scientific summary including a documented account of the symposium presentations and associated discussions, video highlights, and also questions that were put to the audience by the Chair, Professor Tony Mok, from The Chinese University of Hong Kong. The key topics covered in the scientific summary are:
- How best to manage patients with nonsquamous cell NSCLC without EGFR/ALK mutations – Dr Ross Soo.
- Therapeutic options for patients with advanced squamous NSCLC – Professor Giorgio Scagliotti.
After attending this symposium, learners will be able to:
- Assess the new treatment paradigms for non-mutated advanced and metastatic non-squamous NSCLC, and explain how to best apply them to individualized patient care in their daily practice.
- Describe the rapidly expanding and complex range of treatment options for advanced and metastatic squamous NSCLC, and explain how to best apply them to individualized patient care in their daily practice.
This program is made possible thanks to independent educational sponsorship from Eli Lilly and Company.
Produced by Springer Healthcare IME.
Telephone +44 (0) 203 192 2023
Springer Healthcare IME
The Campus, 4 Crinan Street
London, N1 9XW, UK